24.08.2013 Views

2008 Barcelona - European Society of Human Genetics

2008 Barcelona - European Society of Human Genetics

2008 Barcelona - European Society of Human Genetics

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

Cytogenetics<br />

lona, Spain.<br />

Cytogenetically balanced chromosome rearrangements constitute<br />

chromosome abnormalities that may be associated with mental retardation<br />

and dysmorphic features, suggesting possible cryptic imbalances<br />

in the breakpoint . Due to the limited resolution <strong>of</strong> conventional<br />

cytogenetics, new molecular techniques are required for their detection,<br />

such as array-CGH .<br />

We present two patients with phenotypic abnormalities and de novo<br />

cytogenetically balanced rearrangements . After analysing them by 1<br />

Mb array-CGH, imbalances were observed in both cases (just one<br />

case involving the breakpoints) .<br />

In patient 1, who presented deafness, hidrocephaly and coloboma,<br />

the karyotype was 46,XX,t(6;13)(q23;q31)dn . Array-CGH detected a<br />

13q32 .2 deletion, 13q33 .1 duplication, 1q44 duplication and 16q21-22<br />

deletion. The last one is the only confirmed abnormality by FISH for<br />

the time being (BACs RP11-89O14 and RP11-468F3), but it has been<br />

described as a polymorphism .<br />

Patient 2, with a Silver-Russell-like phenotype, showed the karyotype<br />

46,XX,inv(7)(q21 .12q34)dn . Array-CGH did not show any deletion in<br />

the breakpoints, but highlighted a de novo microdeletion <strong>of</strong> 5Mb at<br />

3p12.3-3p13, confirmed by FISH (BACs RP11-781E19 and RP11-<br />

59O5) .<br />

In relation to patient 2, the only confirmed case for now, a review <strong>of</strong><br />

similar reported cases has been performed . Although none <strong>of</strong> them<br />

has an identical microdeletion, common features have been observed,<br />

ranging from minor anomalies to growth and mental retardation, and<br />

brain, heart and lung malformations . Many genes <strong>of</strong> 3p12 .3-3p13 region<br />

remain still unknown, making it difficult to establish a good genotype-phenotype<br />

correlation .<br />

These results underline the importance <strong>of</strong> the use <strong>of</strong> molecular cytogenetics<br />

in patients with apparently cytogenetically balanced chromosome<br />

rearrangements associated with phenotypic abnormalities .<br />

P02.022<br />

Oligonucleotide array-cGH in postnatal cytogenetics<br />

H. Tönnies 1 , A. Caliebe 1 , I. Martin-Subero 1 , S. Gesk 1 , N. Husemeyer 1 , I.<br />

Stefanova 2 , G. Gillessen-Kaesbach 2 , K. Bruhn 3 , U. Stephani 3 , G. Krüger 4 , M.<br />

Kautza 5 , J. Weimer 6 , R. Siebert 1 ;<br />

1 Institut für <strong>Human</strong>genetik, Kiel, Germany, 2 Institut für <strong>Human</strong>genetik, Lübeck,<br />

Germany, 3 Klinik für Neuropädiatrie, Kiel, Germany, 4 Abteilung für Medizinische<br />

Genetik, Rostock, Germany, 5 Praxis für <strong>Human</strong>genetik, Kiel, Germany, 6 Onkologisches<br />

Labor der Klinik für Gynäkologie und Geburtshilfe, Kiel, Germany.<br />

High-resolution array-CGH (aCGH) allows the detection <strong>of</strong> small, submicroscopic<br />

imbalances in euchromatic chromosomal segments . We<br />

have performed aCGH for the detection <strong>of</strong> constitutional imbalances<br />

in 129 patients with normal karyotype and developmental delay and/<br />

or various malformations, dysmorphisms, or complicated epilepsy <strong>of</strong><br />

unknown etiology using 44K, 105K, and 244K oligonucleotide arrays<br />

(Agilent) . In 22 <strong>of</strong> 129 patients euchromatic imbalances have been detected<br />

(~17%) by aCGH and verified by FISH analyses. In seven out <strong>of</strong><br />

18 cases where parental samples were available for verification analyses,<br />

it could be shown that the euchromatic imbalance (3 deletions: 0 .4<br />

Mb-1 .9 Mb; 4 duplications: 1 .3 Mb-5 .3 Mb) has been transmitted from<br />

a phenotypically normal parent . Overall, in 14 <strong>of</strong> 129 patients (~11%)<br />

a de novo aberration has been detected; some <strong>of</strong> thosw representing<br />

well known, others recently established microdeletion and microduplication<br />

syndromes . In addition to the 129 patients, 19 patient samples<br />

were analyzed to further characterize a chromosomal aberration detected<br />

initially by conventional cytogenetics . In eleven <strong>of</strong> these cases<br />

(~58%) including complex translocations and ring chromosomes, the<br />

imbalance(s) could be characterized successfully in more detail using<br />

aCGH . Hybridization <strong>of</strong> microdissected chromosome material <strong>of</strong> a supernumerary<br />

ring chromosome 19 onto a 105 K array allowed the high<br />

resolution mapping <strong>of</strong> the nonlinear euchromatic content . However,<br />

in eight preselected cytogenetic samples no euchromatic imbalance<br />

could be detected by aCGH using whole genomic DNA . In summary,<br />

aCGH and array-hybridization <strong>of</strong> microdissected chromosomes are<br />

highly informative methods for the detection and characterization <strong>of</strong><br />

chromosomal imbalances in postnatal cytogenetics .<br />

P02.023<br />

Array cGH detection <strong>of</strong> genomic imbalances in 370 patients with<br />

unresolved retardation syndrome<br />

U. Koehler, E. Holinski-Feder, E. Holinski-Feder;<br />

Medizinisch Genetisches Zentrum, Munich, Germany.<br />

Genomic imbalances are a major cause <strong>of</strong> mental retardation and developmental<br />

delay in patients with congenital and developmental abnormalities<br />

. With the advent <strong>of</strong> whole genome array-CGH analysis,<br />

the number especially <strong>of</strong> interstitial genomic imbalances increased<br />

dramatically . Here we present our results <strong>of</strong> array-CGH investigations<br />

in 370 cases <strong>of</strong> patients with retardation syndromes and dysmorphic<br />

features using the Cytochip v2 BAC array (BlueGnome, Cambridge) .<br />

Among these cases we found 55 genomic imbalances (15%) . Seven<br />

(2,1%) <strong>of</strong> the genomic imbalances were telomeric (3 deletions, 4 duplications)<br />

and 48 interstitial (12,9%, 28 deletions, 12 duplications) .<br />

Of these interstitial imbalances 28 were >1 Mb in size (average 3,5)<br />

whereas 20 were smaller or equal to 1 Mb in size . Four aberrations included<br />

terminal deletion/duplication events (three de novo, one inherited<br />

from a balanced father) . 8 cases (2,4%) were patients with known<br />

microdeletion or microduplication syndromes (two microdeletions<br />

22q11 .2, two microdeletions 17p11 .2, two microdeletions 15q11 .2q13,<br />

two microduplications 17p11 .2) . FISH has not been performed prior<br />

to the array CGH, as no obvious indication <strong>of</strong> the referrals existed .<br />

All <strong>of</strong> the detected gains and losses have been confirmed by either<br />

FISH or MLPA . A small 0,8 Mb deletion in the long arm <strong>of</strong> chromosome<br />

2 (2q22.3) lead to the molecular genetically confirmed diagnosis <strong>of</strong><br />

Mowat-Wilson syndrome . To summarize, array CGH is a very powerful<br />

tool to detect genomic imbalances in at up to 15% <strong>of</strong> previously<br />

unresolved cases .<br />

P02.024<br />

Genome-wide analysis <strong>of</strong> DNA copy-number changes in subjects<br />

with mental retardation<br />

R. Ciccone, A. Vetro, O. Zuffardi;<br />

University <strong>of</strong> Pavia, Pavia, Italy.<br />

During the last three years we analyzed more than 1000 individuals<br />

affected by mental retardation and/or congenital anomalies by oligobased<br />

array-CGH . About 300 <strong>of</strong> these subjects had a known imbalance<br />

already defined by conventional cytogenetics and the genomewide<br />

analysis helped us to better characterize these rearrangements .<br />

A group <strong>of</strong> 703 individuals with normal karyotype was investigated by<br />

using two different microarrays (Agilent 44K and 244K) which have<br />

an average resolution <strong>of</strong> about 100Kb and 20Kb respectively . Among<br />

those investigated by the 44K chip (557), 126 (22,6%) subjects were<br />

unbalanced and 82 (14,7%) had imbalances causative <strong>of</strong> their phenotype<br />

. 146 patients were investigated through the 244K chip; 46 (31,5%)<br />

were unbalanced and 22 (15%) such imbalances were pathogenic . We<br />

are not able to establish whether the remaining 66 imbalances were<br />

causative or not . In fact most <strong>of</strong> them were inherited from a normal<br />

parent whereas in few cases we could not investigate the parents . Interestingly,<br />

our study highlighted some peculiar rearrangements such<br />

as de novo triplications or two independent genomic disorders in the<br />

same patient . On the other hand, our study demonstrate that increasing<br />

the resolutions may improve the detection rate, although the percentage<br />

<strong>of</strong> potentially causative imbalances detected using these two<br />

platforms is not significantly different.<br />

P02.025<br />

Validation <strong>of</strong> BAc-array cGH using a different array cGH<br />

platform<br />

U. Heinrich1 , L. Melanie1 , H. Tanja1 , S. Kai1 , A. Polten2 , R. Imma1 ;<br />

1Centre for <strong>Human</strong> <strong>Genetics</strong> and Laboratory Medicine, Martinsried, Germany,<br />

2Agilent, Waldbronn, Germany.<br />

Array CGH utilizing spotted BAC/PAC clone microarrays has recently<br />

been introduced as a valuable diagnostic tool for the detection <strong>of</strong> chromosomal<br />

imbalances in patients with mental retardation and developmental<br />

delay . Since diagnostics generally requires a binding medical<br />

opinion, results from array CGH analyses need to be validated to avoid<br />

false positive results . The currently most widely used validation method<br />

is FISH <strong>of</strong> metaphase spreads using the same BAC/PAC clone that<br />

has been identified as conspicuous on the chip array. Whereas FISH<br />

is the method <strong>of</strong> choice for the validation <strong>of</strong> deletions, duplications are<br />

generally difficult to interpret. We therefore used a second, oligonucle-

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!